Innonco Overview

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Innonco General Information

Description

Developer of cancer drugs by targeting immunologic derangement designed to improve the life of cancer patients. The company is currently operating in stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innonco Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Stealth
1. Early Stage VC 01-Jan-2018 Completed Stealth
To view Innonco’s complete valuation and funding history, request access »

Innonco FAQs

  • Where is Innonco headquartered?

    Innonco is headquartered in .

  • What industry is Innonco in?

    Innonco’s primary industry is Drug Discovery.

  • Is Innonco a private or public company?

    Innonco is a Private company.

  • What is Innonco’s current revenue?

    The current revenue for Innonco is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process